查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446908

環糊精市場：按類型、最終用戶產業：2023-2032 年全球機會分析與產業預測

Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 354 Pages | 商品交期: 2-3個工作天內

價格

2022年全球環糊精市場價值為3.34億美元，預計到2032年將達到5.796億美元，2023年至2032年的複合年成長率為5.7%。

環糊精市場-IMG1

環糊精是由α-1,4-糖苷鍵連接的葡萄糖單元所組成的環狀寡糖。這些分子具有獨特的圓環或截錐結構，其特徵是疏水性中心空腔和親水性外表面。環糊精以其與其他分子形成包合物的能力而聞名，從而使客體分子被封裝在其中心空腔內。這項特性使環糊精可用於提高各種行業（如藥品、食品和化妝品）中各種化合物的溶解度、穩定性和生物利用度等應用。

對永續性和綠色化學實踐的日益重視也推動了環糊精市場的發展。環糊精可生物分解性且對環境友好，這使其對於優先考慮環保替代品的應用具有吸引力。使用環糊精代替傳統化學品符合世界對永續實踐的推動，並吸引了尋求環保解決方案的行業。

此外，各行業正在進行的研究和開發也有助於環糊精市場的擴大。研究人員正在探索利用環糊精獨特性質的新應用和配方。這包括新型藥物輸送系統、改進的封裝技術以及在農業和紡織等領域的創新應用。新應用的不斷發現和獨特配方的開發正在推動對環糊精的需求。

然而，監管的考量也正在影響環糊精市場。環糊精用於多種應用，包括藥品和食品，因此遵守嚴格的監管要求至關重要。獲得含環糊精產品的監管核准既耗時又昂貴。此外，不斷變化的監管環境和合規標準可能需要製造商不斷適應，從而增加市場的複雜性。

另一方面，在食品和飲料領域，環糊精被用作包封劑、風味改進劑和穩定劑。環糊精有助於提高產品品質、口味和保存期限。隨著消費者越來越尋求更健康、更天然的成分，環糊精遮罩不良味道和氣味的能力使其對食品製造商有價值。潔淨標示產品的趨勢和機能性食品的需求進一步推動了該細分市場的機會。

環糊精市場按類型、最終用戶行業和地區細分。依類型分類，市場分為α-環糊精、BETA-環糊精和γ-環糊精。以最終用戶產業為基礎，分為食品、藥品、化妝品及個人護理、化學品、紡織品等。按地區分類，我們研究了北美、歐洲、亞太地區和拉丁美洲地區 (LAMEA) 的市場。

相關人員的主要利益

  • 本報告定量分析了 2022 年至 2032 年環糊精市場分析的細分市場、當前趨勢、估計/趨勢和動態，以確定有前景的環糊精市場機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的業務決策並加強供應商和買家網路。
  • 環糊精市場細分的詳細分析將有助於確定市場機會。
  • 我們根據每個地區的主要國家對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前地位的清晰了解。
  • 該報告包括對區域和全球環糊精市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 製造能力
  • 投資機會
  • 供應鏈分析與供應商利潤
  • 科技趨勢分析
  • 按產品/細分市場分類的公司市場區隔分析
  • 新產品開發/主要企業產品矩陣
  • 國家、區域和全球各級的患者/流行病學資料
  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 導入/匯出分析/資料
  • 主要企業詳細資料（Excel 格式，包括位置、聯絡資訊、供應商/供應商網路等）
  • 全球/區域/國家層級參與者的市場佔有率分析
  • SWOT分析
  • 成交量市場規模及預測

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 價值鏈分析
  • 價格分析
  • 關鍵監管分析
  • 專利形勢

第4章環糊精市場：依類型

  • 概述
  • α-環糊精
  • BETA-環糊精
  • γ-環糊精

第5章環糊精市場：依最終用戶產業

  • 概述
  • 食品
  • 藥品
  • 化妝品和個人護理
  • 化學
  • 纖維
  • 其他

第6章環糊精市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第7章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第8章 公司簡介

  • Cayman Chemical Company
  • Cambrex Corporation
  • Wellona Pharma Private Limited.
  • Wacker Chemie AG.
  • Cyclolab
  • Tocopharm Co. Limited
  • Roquette Freres
  • Midas Pharma GmbH
  • Ligand Pharmaceuticals Incorporated
  • Cyclo Therapeutics, Inc
Product Code: A107969

The global cyclodextrin market was valued at $334.0 million in 2022 and is estimated to reach $579.6 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.

Cyclodextrin Market - IMG1

Cyclodextrins are cyclic oligosaccharides composed of glucose units linked by alpha-1,4-glycosidic bonds. These molecules have a unique torus or truncated cone structure, characterized by a hydrophobic central cavity and a hydrophilic outer surface. Cyclodextrins are known for their ability to form inclusion complexes with other molecules, where the guest molecule can be encapsulated within their central cavity. This property makes cyclodextrins useful in various industries, including pharmaceuticals, food, cosmetics, and more, for applications such as improving the solubility, stability, and bioavailability of different compounds.

The growing emphasis on sustainability and green chemistry practices is another driving force for the cyclodextrin market. Cyclodextrins are biodegradable and environmentally friendly, making them attractive for applications where eco-friendly alternatives are prioritized. The use of cyclodextrins in place of traditional chemicals aligns with the global push towards sustainable practices, appealing to industries seeking environmentally conscious solutions.

Moreover, ongoing research and development activities in various industries contribute to the expansion of the cyclodextrin market. Researchers are exploring new applications and formulations that leverage the unique properties of cyclodextrins. This includes novel drug delivery systems, improved encapsulation techniques, and innovative uses in areas such as agriculture and textiles. The continuous discovery of novel applications and the development of proprietary formulations drive the demand for cyclodextrins.

However, regulatory considerations also impact the cyclodextrin market. As cyclodextrins are used in various applications, including pharmaceuticals and food products, adherence to stringent regulatory requirements is crucial. Obtaining regulatory approvals for cyclodextrin-containing products can be time-consuming and expensive. Additionally, evolving regulatory landscapes and changes in compliance standards may require continuous adaptation by manufacturers, adding a layer of complexity to the market.

On the contrary, in the food and beverage sector, cyclodextrins find applications as encapsulating agents, flavor modifiers, and stabilizers. They contribute to improved product quality, taste, and shelf life. As consumers increasingly seek healthier and more natural ingredients, cyclodextrins, with their ability to mask undesirable flavors and odors, become invaluable for food manufacturers. The trend towards clean-label products and the demand for functional foods further drive the opportunities in this market segment.

The cyclodextrin market is segmented on the basis of type, end-user industry, and region. On the basis of type, the market is categorized into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. On the basis of end-user industry, it is divided into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The global cyclodextrin market profiles leading players that include Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette Freres, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.

Other key players involved in the manufacturing of cyclodextrin includes Zibo Qianhui biological technology co., ltd, Xi'an Deli Biochemical Industry Co., Ltd, Merck KgaA, Otto Chemie Pvt. Ltd., VIO CHEMICALS, Ashland, and TCI Chemicals Pvt. Ltd. The global cyclodextrin market report provides in-depth competitive analysis as well as profiles of these major players.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cyclodextrin market analysis from 2022 to 2032 to identify the prevailing cyclodextrin market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cyclodextrin market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cyclodextrin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Manufacturing Capacity
  • Investment Opportunities
  • Supply Chain Analysis & Vendor Margins
  • Technology Trend Analysis
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Type

  • Alpha-Cyclodextrin
  • Beta-Cyclodextrin
  • Gamma-Cyclodextrin

By End-User Industry

  • Food
  • Pharmaceutical
  • Cosmetics and Personal Care
  • Chemical
  • Textile
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cayman Chemical Company
    • Cambrex Corporation
    • Wellona Pharma Private Limited.
    • Wacker Chemie AG.
    • Cyclolab
    • Tocopharm Co. Limited
    • Roquette Freres
    • Midas Pharma GmbH
    • Ligand Pharmaceuticals Incorporated
    • Cyclo Therapeutics, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Value Chain Analysis
  • 3.6. Pricing Analysis
  • 3.7. Key Regulation Analysis
  • 3.8. Patent Landscape

CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Alpha-Cyclodextrin
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Beta-Cyclodextrin
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Gamma-Cyclodextrin
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Food
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Pharmaceutical
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Cosmetics and Personal Care
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Chemical
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Textile
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country
  • 5.7. Others
    • 5.7.1. Key market trends, growth factors and opportunities
    • 5.7.2. Market size and forecast, by region
    • 5.7.3. Market share analysis by country

CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by End-User Industry
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by End-User Industry
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by End-User Industry
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by End-User Industry
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by End-User Industry
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by End-User Industry
      • 6.3.4.2. UK
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by End-User Industry
      • 6.3.4.3. France
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by End-User Industry
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by End-User Industry
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by End-User Industry
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by End-User Industry
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by End-User Industry
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by End-User Industry
      • 6.4.4.2. India
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by End-User Industry
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by End-User Industry
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by End-User Industry
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by End-User Industry
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by End-User Industry
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by End-User Industry
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by End-User Industry
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by End-User Industry
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by End-User Industry
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by End-User Industry

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Cayman Chemical Company
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Cambrex Corporation
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Wellona Pharma Private Limited.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. Wacker Chemie AG.
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Cyclolab
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Tocopharm Co. Limited
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Roquette Freres
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Midas Pharma GmbH
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. Ligand Pharmaceuticals Incorporated
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Cyclo Therapeutics, Inc
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 03. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
  • TABLE 05. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
  • TABLE 07. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
  • TABLE 09. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 11. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 (TONS)
  • TABLE 13. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 (TONS)
  • TABLE 15. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 (TONS)
  • TABLE 17. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 (TONS)
  • TABLE 19. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 (TONS)
  • TABLE 21. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 (TONS)
  • TABLE 23. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 (TONS)
  • TABLE 25. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 27. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 29. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 31. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 33. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 34. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 35. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 37. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 38. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 39. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 41. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 42. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 43. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 45. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 47. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 48. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 49. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 51. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 53. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 55. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 56. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 57. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 59. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 60. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 61. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 63. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 64. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 65. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 67. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 68. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 69. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 71. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 72. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 73. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 75. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 76. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 77. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 79. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 81. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 82. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 83. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 85. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 86. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 87. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 89. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 90. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 91. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 93. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 95. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 97. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 98. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 99. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 101. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 102. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 103. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 105. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 106. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 107. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 108. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
  • TABLE 109. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 110. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 111. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 112. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 113. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 114. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 115. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 116. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 117. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 118. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 119. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 121. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 122. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
  • TABLE 123. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
  • TABLE 124. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
  • TABLE 125. CAYMAN CHEMICAL COMPANY: KEY EXECUTIVES
  • TABLE 126. CAYMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
  • TABLE 127. CAYMAN CHEMICAL COMPANY: PRODUCT SEGMENTS
  • TABLE 128. CAYMAN CHEMICAL COMPANY: SERVICE SEGMENTS
  • TABLE 129. CAYMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
  • TABLE 130. CAYMAN CHEMICAL COMPANY: KEY STRATERGIES
  • TABLE 131. CAMBREX CORPORATION: KEY EXECUTIVES
  • TABLE 132. CAMBREX CORPORATION: COMPANY SNAPSHOT
  • TABLE 133. CAMBREX CORPORATION: PRODUCT SEGMENTS
  • TABLE 134. CAMBREX CORPORATION: SERVICE SEGMENTS
  • TABLE 135. CAMBREX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. CAMBREX CORPORATION: KEY STRATERGIES
  • TABLE 137. WELLONA PHARMA PRIVATE LIMITED.: KEY EXECUTIVES
  • TABLE 138. WELLONA PHARMA PRIVATE LIMITED.: COMPANY SNAPSHOT
  • TABLE 139. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT SEGMENTS
  • TABLE 140. WELLONA PHARMA PRIVATE LIMITED.: SERVICE SEGMENTS
  • TABLE 141. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT PORTFOLIO
  • TABLE 142. WELLONA PHARMA PRIVATE LIMITED.: KEY STRATERGIES
  • TABLE 143. WACKER CHEMIE AG.: KEY EXECUTIVES
  • TABLE 144. WACKER CHEMIE AG.: COMPANY SNAPSHOT
  • TABLE 145. WACKER CHEMIE AG.: PRODUCT SEGMENTS
  • TABLE 146. WACKER CHEMIE AG.: SERVICE SEGMENTS
  • TABLE 147. WACKER CHEMIE AG.: PRODUCT PORTFOLIO
  • TABLE 148. WACKER CHEMIE AG.: KEY STRATERGIES
  • TABLE 149. CYCLOLAB: KEY EXECUTIVES
  • TABLE 150. CYCLOLAB: COMPANY SNAPSHOT
  • TABLE 151. CYCLOLAB: PRODUCT SEGMENTS
  • TABLE 152. CYCLOLAB: SERVICE SEGMENTS
  • TABLE 153. CYCLOLAB: PRODUCT PORTFOLIO
  • TABLE 154. CYCLOLAB: KEY STRATERGIES
  • TABLE 155. TOCOPHARM CO. LIMITED: KEY EXECUTIVES
  • TABLE 156. TOCOPHARM CO. LIMITED: COMPANY SNAPSHOT
  • TABLE 157. TOCOPHARM CO. LIMITED: PRODUCT SEGMENTS
  • TABLE 158. TOCOPHARM CO. LIMITED: SERVICE SEGMENTS
  • TABLE 159. TOCOPHARM CO. LIMITED: PRODUCT PORTFOLIO
  • TABLE 160. TOCOPHARM CO. LIMITED: KEY STRATERGIES
  • TABLE 161. ROQUETTE FRERES: KEY EXECUTIVES
  • TABLE 162. ROQUETTE FRERES: COMPANY SNAPSHOT
  • TABLE 163. ROQUETTE FRERES: PRODUCT SEGMENTS
  • TABLE 164. ROQUETTE FRERES: SERVICE SEGMENTS
  • TABLE 165. ROQUETTE FRERES: PRODUCT PORTFOLIO
  • TABLE 166. ROQUETTE FRERES: KEY STRATERGIES
  • TABLE 167. MIDAS PHARMA GMBH: KEY EXECUTIVES
  • TABLE 168. MIDAS PHARMA GMBH: COMPANY SNAPSHOT
  • TABLE 169. MIDAS PHARMA GMBH: PRODUCT SEGMENTS
  • TABLE 170. MIDAS PHARMA GMBH: SERVICE SEGMENTS
  • TABLE 171. MIDAS PHARMA GMBH: PRODUCT PORTFOLIO
  • TABLE 172. MIDAS PHARMA GMBH: KEY STRATERGIES
  • TABLE 173. LIGAND PHARMACEUTICALS INCORPORATED: KEY EXECUTIVES
  • TABLE 174. LIGAND PHARMACEUTICALS INCORPORATED: COMPANY SNAPSHOT
  • TABLE 175. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT SEGMENTS
  • TABLE 176. LIGAND PHARMACEUTICALS INCORPORATED: SERVICE SEGMENTS
  • TABLE 177. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 178. LIGAND PHARMACEUTICALS INCORPORATED: KEY STRATERGIES
  • TABLE 179. CYCLO THERAPEUTICS, INC: KEY EXECUTIVES
  • TABLE 180. CYCLO THERAPEUTICS, INC: COMPANY SNAPSHOT
  • TABLE 181. CYCLO THERAPEUTICS, INC: PRODUCT SEGMENTS
  • TABLE 182. CYCLO THERAPEUTICS, INC: SERVICE SEGMENTS
  • TABLE 183. CYCLO THERAPEUTICS, INC: PRODUCT PORTFOLIO
  • TABLE 184. CYCLO THERAPEUTICS, INC: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. CYCLODEXTRIN MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF CYCLODEXTRIN MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN CYCLODEXTRIN MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN CYCLODEXTRIN MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL CYCLODEXTRIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PRICING ANALYSIS: CYCLODEXTRIN MARKET 2022 AND 2032
  • FIGURE 12. IMPACT OF KEY REGULATION: CYCLODEXTRIN MARKET
  • FIGURE 13. PATENT ANALYSIS BY COMPANY
  • FIGURE 14. PATENT ANALYSIS BY COUNTRY
  • FIGURE 15. CYCLODEXTRIN MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR FOOD, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR CHEMICAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR TEXTILE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. CYCLODEXTRIN MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 27. U.S. CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. CANADA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. MEXICO CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. GERMANY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. FRANCE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. ITALY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF EUROPE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. JAPAN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. BRAZIL CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: CYCLODEXTRIN MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2022